Related references
Note: Only part of the references are listed.Role of Thiopurine and Anti-TNF Therapy in Lymphoma in Inflammatory Bowel Disease
Lisa J. Herrinton et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
David S. Kotlyar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Hepatosplenic T-cell lymphoma in patients receiving TNF-α inhibitor therapy: expanding the groups at risk
Deepak Parakkal et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1-Based Therapies
Michael Elashoff et al.
GASTROENTEROLOGY (2011)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Importance of Early Splenectomy in Patients with Hepatosplenic T-Cell Lymphoma and Severe Thrombocytopenia
Andrew A. Gumbs et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Subcutaneous panniculitis-like T-cell lymphoma in a patient receiving etanercept for rheumatoid arthritis
C. Michot et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Risk of Lymphoma Associated With Combination Anti-Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
Corey A. Siegel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Collateral damage: the conundrum of drug safety
E. A. M. Gale
DIABETOLOGIA (2009)
Inflammatory Bowel Disease, Clinical
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-α blocking agents: two cases
S. Lourari et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
Risk of Hepatotoxicity Associated with the Use of Telithromycin: A Signal Detection Using Data Mining Algorithms
Yan Chen et al.
ANNALS OF PHARMACOTHERAPY (2008)
Sezary syndrome in a patient receiving infliximab for ankylosing spondylitis
J. N. Dauendorffer et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease
Ann Corken Mackey et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
E Baecklund et al.
ARTHRITIS AND RHEUMATISM (2006)
Atypical CD8(+) cutaneous T-cell lymphoma after immunomodulatory therapy
Cindy Berthelot et al.
CLINICAL LYMPHOMA & MYELOMA (2006)
Haematopoietic malignancies in rheumatoid arthritis:: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
J Askling et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
A Kandiel et al.
GUT (2005)
Mycosis fungoides-associated follicular mucinosis under adalimumab
S Dalle et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Risk of haematopoietic cancer in patients with inflammatory bowel disease
J Askling et al.
GUT (2005)
Aggressive cutaneous T-cell lymphomas after TNFα blockade
AE Adams et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Inflammatory bowel disease is not associated with an increased risk of lymphoma
JD Lewis et al.
GASTROENTEROLOGY (2001)
Share Paper
